GlobalData on MSN
Merck KGaA doses first patient in phase III programme of enpatoran
Both ELOWEN-1 and ELOWEN-2 are planned to be conducted at 266 sites in 26 countries.
David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck KGaA, Darmstadt, Germany ...
Many people with lupus have hair loss or thinning hair. Find out what you can do to manage hair loss and keep your hair as healthy as possible. Many people with lupus have skin problems, like rashes ...
Winston-Salem, NC and Charlottesville, VA - Much of the variability in severity, organ involvement, and response to therapy among patients with systemic lupus erythematosus (SLE) is blamed on ...
Very often, people with lupus are photosensitive, meaning their skin is very sensitive to ultraviolet light. Breakouts ...
Hosted on MSN
Living well with autoimmune skin conditions
Autoimmune skin conditions like lupus, vasculitis, and psoriasis can affect far more than the skin itself. Clinics are increasingly blending conventional treatments with lifestyle-based and ...
Often diagnosed in the teenage years, childhood-onset lupus is a serious, potentially fatal autoimmune disease that causes the body to attack itself. For as many as 10,000 U.S. youths, it can bring ...
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results